Could a skin cream boost immunotherapy for advanced cancer?
Disease control
Recruiting now
This early-stage study tests whether a topical cream called diphencyprone (DPCP) can make immunotherapy (PD-1/PD-L1 inhibitors) work better for people with advanced cancer that has spread to the skin. About 100 participants will apply the cream twice a week for 12 weeks alongside…
Phase: PHASE1 • Sponsor: Nicholas Gulati • Aim: Disease control
Last updated May 15, 2026 06:07 UTC